• No results found

Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

N/A
N/A
Protected

Academic year: 2020

Share "Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 Disposition of patients
Table 1 Demographics and baseline characteristics
Figure 2 Plasma pharmacokinetics (PK) of cannabidiol (CBD) and metabolites
Figure 3 Percentage change from baseline to end of treatment in plasma clobazam (CLB) and N-desmethylclobazam (N-CLB) concentrations
+2

References

Related documents

Several serological tests designed to detect antibodies to immunodominant Mycobacterium bovis antigens have recently emerged as ancillary tests for the detection of bovine

The orientation program is intended to offer the library and media center’s services and resources to the user group, to encourage them to make use of their services and

Here, the role of the Antarctic surface height for meridional heat transport and local radiative feedbacks, including the surface albedo feedback, was investigated based on CO

Note that the spots of Rat E-cadherin oligo spot showed yellow whereas the spots of Mouse Cyp1a1 oligo showed green, indicating − 499-CpG methylation level of control mouse is

The cell proliferation rate in the PSMG3-AS1 group increased signi fi cantly, while the miR-143-3p group decreased. There was no signi fi cant difference in cell proliferation between